INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test

 INOVIQ has the exclusive option to license rights to the development and commercialisation of UQ’s exosome-based early detection test for ovarian cancer to improve women’s health outcomes and help save lives Using exosomes as a source of accurate biomarkers for cancer Exosomes are a type of extracellular vesicle (EV) that are small particles (around 30-150 nm) released by most cells into bioflui